Interventional Cardiology Devices | Market Insights | Japan | 2021
The US IC device market will continue to be negatively affected by policies that contribute to declining ASPs, such as Medicare coverage for low-complexity catheterization procedures performed in nonhospital facilities, reimbursement equalization between different sites of service, and cost-containment measures. Moreover, the COVID-19 global pandemic will result in lost procedure volumes in the short term. However, these effects will be mitigated by the emergence of specialized premium-priced technologies to diagnose and treat complex CADs from 2022 through 2029.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in the US, with market projections across a 10-year period.
